Open Access
CC BY 4.0 · Endosc Int Open 2025; 13: a25420880
DOI: 10.1055/a-2542-0880
Original article

Prevalence and endoscopic-histological correlation of premalignant gastric lesions at a university hospital in Uruguay

Authors

  • Ignacio Moratorio

    1   Unidad Académica Gastroenterología, Hospital de Clinicas Doctor Manuel Quintela, Montevideo, Uruguay (Ringgold ID: RIN226552)
  • Adrian Canavesi

    1   Unidad Académica Gastroenterología, Hospital de Clinicas Doctor Manuel Quintela, Montevideo, Uruguay (Ringgold ID: RIN226552)
  • Carolina Olano

    1   Unidad Académica Gastroenterología, Hospital de Clinicas Doctor Manuel Quintela, Montevideo, Uruguay (Ringgold ID: RIN226552)
  • Klaus Mönkemüller

    1   Unidad Académica Gastroenterología, Hospital de Clinicas Doctor Manuel Quintela, Montevideo, Uruguay (Ringgold ID: RIN226552)

Abstract

Background and study aims

Although chronic atrophic gastritis (CAG), intestinal metaplasia (IM), and dysplasia constitute gastric pre-neoplastic conditions of gastric cancer (GC), data on endoscopic correlation and the prevalence in many South American countries are scarce. The aims of this study were to establish prevalence and perform endoscopic-histological correlation of gastric pre-neoplastic conditions using high-definition white light endoscopy (WLE) and to determine interobserver agreement for endoscopic findings for CAG and IM.

Patients and methods

A prospective, observational, descriptive, cross-sectional study was carried out at a Uruguayan hospital during a 6-month period. Risk was stratified according to Operative Link for Gastritis Assessment and Operative Link for Gastric Intestinal Metaplasia stage for CAG and IM, respectively. An independent and blinded second observer was included to determine interobserver endoscopic and histologic agreement.

Results

A total of 102 patients (mean age 57 years ± 1.6 years, 68.6% woman) were included. Prevalence of histological CAG and IM were 38.2% and IM 31.4%, respectively. Endoscopic-histological correlation for CAG had kappa index 0.063, sensitivity 46%, and specificity 60%. For endoscopic IM, the kappa index was 0.216, sensitivity 22%, and specificity 96%. Interobserver variability was good for gastric fold flattening and very good in the presence of whitish-greyish plaques for CAG and IM, respectively.

Conclusions

The endoscopic-histological correlation of both CAG and IM was low, raising the need for biopsy for diagnosis in all cases, regardless of HD-WLE findings. Although prevalence of gastric pre-neoplastic conditions in this group of Uruguayan patients was comparable to those described in countries with a high incidence of GC, a low proportion of high-risk stages (III and IV) was identified.



Publication History

Received: 07 May 2024

Accepted after revision: 14 February 2025

Accepted Manuscript online:
18 February 2025

Article published online:
14 March 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Bibliographical Record
Ignacio Moratorio, Adrian Canavesi, Carolina Olano, Klaus Mönkemüller. Prevalence and endoscopic-histological correlation of premalignant gastric lesions at a university hospital in Uruguay. Endosc Int Open 2025; 13: a25420880.
DOI: 10.1055/a-2542-0880
 
  • References

  • 1 https://gco.iarc.who.int/media/globocan/factsheets/cancers/7-stomach-fact-sheet.pdf
  • 2 Correa P. Gastric cancer: Overview. Gastroenterol Clin North Am 2013; 42: 211-217
  • 3 Comisión Honoraria de Lucha Contra el Cáncer. Situación epidemiológica del Uruguay en relación al cáncer. https://www.comisioncancer.org.uy/Ocultas/SITUACION-EPIDEMIOLOGICA-DEL-URUGUAY-EN-RELACION-AL-CANCER-uc311
  • 4 Leung WK, Wu M-S, Kakugawa Y. et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9: 279-287
  • 5 Pasechnikov V. Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol 2014; 20: 13842
  • 6 Kono S. Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan. World J Gastroenterol 2015; 21: 13113
  • 7 Dixon MF, Genta RM, Yardley JH. et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
  • 8 Yun CY, Kim N, Lee J. et al. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors. Helicobacter 2018; 23: e12542
  • 9 Satoh K, Osawa H, Yoshizawa M. et al. Assessment of atrophic gastritis using the OLGA System. Helicobacter 2008; 13: 225-229
  • 10 Pimentel-Nunes P, Libânio D, Lage J. et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy 2016; 48: 723-730
  • 11 Joo YE, Park HK, Myung DS. et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: A nationwide multicenter prospective study in Korea. Gut Liver 2013; 7: 303-310
  • 12 Rugge M, Meggio A, Pennelli G. et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-636
  • 13 Nagtegaal ID, Odze RD, Klimstra D. et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76: 182-188
  • 14 Lauwers GY, Carneiro F, Graham DY. et al. Tumours of the stomach. In: Lauwers GY, Carneiro F, Hruban RH. , ed. WHO Classification of Tumours of the Digestive System. Lyon: IARC Press; 2010: 45-80
  • 15 Bedoya ÁU, Sansón FG, Yépez Fuertes YV. et al. Prevalencia y severidad de las lesiones precursoras de malignidad en un área de alto riesgo de cáncer gástrico. Pasto 2012. Rev Col Gastroenterol 2012; 27: 275-281
  • 16 Martínez D, Otero W, Ricaurte O. Impacto del sistema OLGA en la detección de gastritis crónica atrófica en Colombia: un estudio de casos y controles. Rev Colomb Gastroenterol 2017; 31: 360
  • 17 Carlin Ronquillo A, Ventura León A, Espinoza Ríos JL. et al. Distribución de estadios de OLGA y OLGIM según edad y estado del Helicobacter pylori en un hospital público nivel III en Lima, Perú. Acta Gastroenterol Latinoam 2021; 51
  • 18 International Agency for Research on Cancer. Global Cancer Observatory. Stomach cancer fact Sheet. https://gco.iarc.who.int/media/globocan/factsheets/cancers/7-stomach-fact-sheet.pdf
  • 19 Ozakay A, Kınacı E, Bayrak S. et al. Helicobacter pylori, intestinal metaplasia, and the accuracy of biopsies in metaplastic gastric mucosa. Int J Clin Exp Med 2017; 10: 5332-5337
  • 20 Rodrigues MF, Guerra MR, de Alvarenga AVR. et al. Helicobacter pylori infection and gastric cancer precursor lesions: prevalence and associated factors in a reference laboratory in southeastern Brazil. Arq Gastroenterol 2019; 56: 419-424
  • 21 Sarem M, Corti R. ¿Por qué es importante detectar la gastritis atrófica y la metaplasia intestinal gástrica? ¿Cuál es la forma adecuada de hacerlo?. Rev Gastroenterol Perú 2020; 40: 260-266
  • 22 Wang J, Xu L, Shi R. et al. Gastric atrophy and intestinal metaplasia before and after helicobacter pylori eradication: A meta-analysis. Digestion 2011; 83: 253-260
  • 23 Olmos JA, Ríos H, Higa R. Prevalence of Helicobacter pylori infection in Argentina. J Clin Gastroenterol 2000; 31: 33-37
  • 24 Reis Júnior JDD dos, Fernandes AB, dos Santos FS. et al. Soroprevalência da infecção por Helicobacter pylori em uma amostra rural do Estado do Amazonas, Brasil. Rev Panamazonica Saude 2012; 3: 33-36
  • 25 Yang I, Woltemate S, Piazuelo MB. et al. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Sci Rep 2016; 6: 18594
  • 26 Whary MT, Avenia JMR, Bravo LE. et al. Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection. Cancer Epidemiol 2020; 67
  • 27 Baek DH, Kim GH, Park DY. et al. Gastric epithelial dysplasia: characteristics and long-term follow-up results after endoscopic resection according to morphological categorization. BMC Gastroenterol 2015; 15: 17
  • 28 Pimentel-Nunes P, Libânio D, Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51: 365-388
  • 29 Eshmuratov A, Nah JC, Kim N. et al. The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci 2010; 55: 1364-1375
  • 30 Contreras C, Araya J, Guidotti F. et al. La alta prevalencia de lesiones premalignas gástricas y el bajo rendimiento diagnóstico de la visión endoscópica son argumentos a favor de la toma sistemática de biopsias gástricas por. Protocolo Sydney Gastroenterol Latinoam 2018; 29: 9-15
  • 31 Kaur G, Raj SM. A study of the concordance between endoscopic gastritis and histological gastritis in an area with a low background prevalence of Helicobacter pylori infection. Singapore Med J 2002; 43: 090-092
  • 32 Hyun YS, Han DS, Bae JH. et al. Interobserver variability and accuracy of high-definition endoscopic diagnosis for gastric intestinal metaplasia among experienced and inexperienced endoscopists. J Korean Med Sci 2013; 28: 744
  • 33 Lim JH, Kim N, Lee HS. et al. Correlation between endoscopic and histological diagnoses of gastric intestinal metaplasia. Gut Liver 2013; 7: 41-50